Search
The following policy resolution was passed unanimously at the May 8, 2020 Advisory Board meeting: The Partnership for Safe Medicines believes that counterfeit medical devices are dangerous to American patients and that the U.S. Food and Drug Administration (FDA) should have the unequivocal power to seize and destroy these dangerous products whether they are found in interstate commerce or in…
Read MoreThis is a reprint of an FDA Alert. When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. May 11, 2020 Company Contact Information Consumers: Lin Leung, MasterPharm, LLC Phone: (866) 630-5600 Email: recall@masterpharm.com Company Announcement MasterPharm, LLC. is…
Read More
PSM is still monitoring public reports of dangerous counterfeit medical supplies and treatments. Here’s a quick round-up of counterfeit news published the week May 4, 2020.
Read More